Insinase features selective kinase response modulators (SKRMs) designed to support healthy cellular insulin function.
- Proprietary formula featuring SKRMs RIAA and acacia which have been shown to modulate insulin function
- SKRMs modulate kinase signaling in adipocytes, which are fat-storing cells involved in glucose utilization and insulin signaling
- In vitro and in vivo testing demonstrated inhibition of IL-6 cytokines which influence insulin function
- Based on in vitro and in vivo testing conducted at Functional Medicine Research Center, the clinical research arm of Metagenics